What is SPARQL?

Knowledge graphs are only as useful as your ability to query them. SPARQL unlocks the full power of graph data by enabling queries that would be extremely complex or impossible in SQL - traversing chains of relationships, finding patterns across heterogeneous data, and aggregating results across federated sources.

SPARQL queries are declarative: you describe the pattern you’re looking for, and the triplestore finds all matches. This makes it natural for questions like “Find all subsidiaries of companies headquartered in the EU that have filed a patent in the last 3 years” - a query that would require multiple joins and subqueries in SQL.

SPARQL also supports federated queries, allowing a single query to span multiple triplestores. This is invaluable for organisations that need to combine internal data with external linked data sources without physically importing the data.

A SPARQL query specifies a graph pattern - a set of triple patterns with variables that the query engine matches against the data. A basic example:

SELECT ?company ?ceo
WHERE {
  ?company a ex:Corporation .
  ?company ex:ceo ?ceo .
  ?company ex:headquarters ex:London .
}

This finds all corporations headquartered in London and returns their CEOs. SPARQL supports four query forms: SELECT (tabular results), CONSTRUCT (return new RDF), ASK (boolean), and DESCRIBE (return everything known about an entity).

Advanced features include OPTIONAL patterns (left-join equivalent), FILTER expressions, GROUP BY / HAVING aggregation, property paths for traversing chains of arbitrary length, and SERVICE for federated queries across remote endpoints.

Wikidata Query Service: Anyone can write SPARQL queries against Wikidata’s 100+ billion triples to answer questions like “Which Nobel Prize winners were born in cities with a population over 1 million?”

Financial compliance: A bank uses SPARQL to traverse beneficial ownership graphs, answering regulatory questions like “Show me all entities with more than 25% ownership that are registered in high-risk jurisdictions”.

Drug discovery: Researchers query a biomedical knowledge graph with SPARQL to find all proteins associated with a disease pathway that have known small-molecule inhibitors, accelerating target identification.